|
|
 |
The BTA TRAK® Assay | | | General Information | |
| Vendor | | Polymedco Inc. | | Item | | The BTA TRAK® Assay | | Catalog Number | | 661105 | | Features | | - Accurate, non-invasive adjunct to cystoscopy
- Superior sensitivity and specificity
- Serial measurements may aid in detecting persistent disease following surgical or medical treatment for bladder cancer
- The BTA TRAK Assay results may predict recurrence by detecting tumors not visualized by cystoscopy
| | Approval | | US FDA | | Analysis Time | | 2.5 Hours | | Method | | Immunoassay | | Instrumentation Needed | | Inquire | | Specificity | | Monitoring specificity = 70% (61 - 79, 95% confidence interval) | | Number of Tests | | 96 well | | Sensitvity | | Monitoring sensitivity = 67% (60 - 73, 95% confidence interval)
| | Pricing |  | Inquire |
| | Related Content | |
| | Product Description | |
| A Powerful New Quantitative Immunoassay for Monitoring Bladder Cancer Patients. Useful in Monitoring Patients for
Disease Progression and Recurrence. | |
| Polymedco Inc. | | Customer Service: (800) 431-2123 | | Web site: http://www.polymedco.com/ | | Please mention Medcompare.com when you contact the vendor. |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
|
